Antiangiogenic therapy for von Hippel-Lindau disease.
Srinivasan
S
Madhusudan
Gaël
G
Deplanque
Jeremy P
JP
Braybrooke
Emma
E
Cattell
Marian
M
Taylor
Pat
P
Price
Marie D
MD
Tsaloumas
Niall
N
Moore
Susan M
SM
Huson
Chris
C
Adams
Peggy
P
Frith
Paul
P
Scigalla
Adrian L
AL
Harris
D000328:Adult; D020533:Angiogenesis Inhibitors / Q000627:therapeutic use*; D001932:Brain Neoplasms / Q000188:drug therapy; D005260:Female; D018325:Hemangioblastoma / Q000188:drug therapy; D006801:Humans; D007211:Indoles / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D011758:Pyrroles / Q000627:therapeutic use*; D019572:Retinal Neoplasms / Q000188:drug therapy; D013120:Spinal Cord Neoplasms / Q000188:drug therapy; D016896:Treatment Outcome; D042461:Vascular Endothelial Growth Factor A / Q000097:blood; D006623:von Hippel-Lindau Disease / Q000188:drug therapy*
D020533:Angiogenesis Inhibitors; D007211:Indoles; D011758:Pyrroles; D042461:Vascular Endothelial Growth Factor A; C116890:Semaxinib